Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anticoagulation in TAPVC Surgical Repair
NCT04241380Unknown
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Feb 2020
- Primary completion
- Oct 2021
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of heparin and aspirin in Total Anomalous Pulmonary Venous Return (TAPVR) (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoints: Incidence of postoperative pulmonary venous obstruction at 2 years, Days of chest drainage at 2 years and 1 more. Status: unknown.
02
Drugs
heparinaspirin
03
Conditions
Total Anomalous Pulmonary Venous Return (TAPVR)
Beyond the preview
Go deeper on NCT04241380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04241380.